Concerns mount over misuse of anaesthetic propofol among US health professionalsBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3673 (Published 08 September 2009) Cite this as: BMJ 2009;339:b3673
- Fred Charatan
Pressure is mounting in the United States for tighter curbs on access to the anaesthetic propofol, amid fears that a growing number of healthcare professionals are becoming addicted to it.
The drug has been implicated in the death of singer Michael Jackson, who died in June, after the Los Angeles coroner’s office said that “lethal levels” had been found in the singer’s body. Propofol, which has been licensed for use since 1986, is given intravenously to induce brief anaesthesia and is not generally available outside hospitals and clinics.
In July the American Association of Nurse Anesthetists warned that “abuse of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial